QUISMOLAT Trademark

Trademark Overview


On Wednesday, July 27, 2016, a trademark application was filed for QUISMOLAT with the United States Patent and Trademark Office. The USPTO has given the QUISMOLAT trademark a serial number of 87118342. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, November 22, 2017. This trademark is owned by Pfizer Inc.. The QUISMOLAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
quismolat

General Information


Serial Number87118342
Word MarkQUISMOLAT
Filing DateWednesday, July 27, 2016
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, November 22, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, November 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJamaica, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJamaica, NY 10017

Trademark Events


Event DateEvent Description
Wednesday, November 22, 2017ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Wednesday, November 22, 2017ABANDONMENT - AFTER PUBLICATION
Tuesday, November 21, 2017TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, July 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2017EXTENSION 1 GRANTED
Thursday, July 6, 2017EXTENSION 1 FILED
Thursday, July 6, 2017TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 31, 2016ASSIGNED TO EXAMINER
Monday, August 1, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, July 30, 2016NEW APPLICATION ENTERED IN TRAM